RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 132 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $23,857,670 | -0.2% | 3,576,862 | +15.4% | 0.16% | -20.8% |
| Q4 2022 | $23,897,068 | -33.2% | 3,099,490 | -7.7% | 0.21% | -16.9% |
| Q3 2022 | $35,748,000 | +113.8% | 3,359,811 | +23.0% | 0.25% | +151.5% |
| Q2 2022 | $16,720,000 | -17.4% | 2,732,087 | -3.4% | 0.10% | +17.9% |
| Q1 2022 | $20,242,000 | -47.1% | 2,827,163 | +26.7% | 0.08% | -27.6% |
| Q4 2021 | $38,234,000 | -35.9% | 2,232,013 | -13.9% | 0.12% | -18.9% |
| Q3 2021 | $59,684,000 | -31.3% | 2,593,836 | +9.0% | 0.14% | -11.7% |
| Q2 2021 | $86,822,000 | – | 2,378,675 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 7,653,061 | $51,045,917 | 68.47% |
| Data Collective IV GP, LLC | 5,941,120 | $39,627,270 | 42.23% |
| MV Management XI, L.L.C. | 1,971,908 | $13,152,626 | 20.13% |
| MIC Capital Management UK LLP | 8,451,758 | $56,373,229 | 10.75% |
| ArchPoint Investors | 1,114,626 | $7,434,555 | 3.23% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $10,066,724 | 1.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,770,451 | $18,478,908 | 0.64% |
| Duquesne Family Office | 1,385,950 | $9,259 | 0.40% |
| ALLEN OPERATIONS LLC | 217,657 | $1,451,772 | 0.37% |
| Cercano Management LLC | 978,051 | $6,523,600 | 0.26% |